Viewing Study NCT06997159

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:32 PM
Ignite Modification Date: 2025-12-29 @ 12:11 AM
Study NCT ID: NCT06997159
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-30
First Post: 2025-05-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
Sponsor: Drugs for Neglected Diseases
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Localized Cutaneous Leishmaniasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Localized Cutaneous Leishmaniasis View